BCAX — BICARA THERAPEUTICS INC

Ownership history in CAXTON CORP  ·  5 quarters on record

This page tracks every 13F SEC filing in which CAXTON CORP reported a position in BICARA THERAPEUTICS INC (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.81% (2025 Q1)
Avg. % of fund
1.38%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 10,941 — 0% 0.76% $173K $15.79
2025 Q2 UNCHANGED 10,941 — 0% 1.03% $102K $9.29
2025 Q1 UNCHANGED 10,941 — 0% 2.81% $142.6M $13.03
2024 Q4 UNCHANGED 10,941 — 0% 1.15% $191K $17.42
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Siren, L.L.C. 2.62% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% TPG GP A, LLC 3Y 1.89% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Deep Track Capital, LP 3Y 0.78% Palo Alto Investors LP 3Y 7Y 0.7%
← Back to CAXTON CORP Holdings